Hints and tips:
...This exhibition at the V&A invites us into the opulent world of master goldsmith Carl Fabergé and his London clientele....
...Lyor Cohen, whom Billboard magazine has described as “more brawler than bridgemaker”, was appointed global head of music in 2016....
...A 2009 Supreme Court case involving prescription drug labels, Wyeth v Levine, greenlighted state laws that are stricter than federal laws....
...SAC and Mr Cohen denied the claims. In December 2015, SAC paid $10m to investors in Wyeth in another class action....
...The case against SAC Capital founder Steven Cohen could also be affected....
...The court was told that he received information on a Sunday in July 2008 and, on the Monday, SAC dumped its entire $700m position in Wyeth and Elan, co-developers of the drug, and bet – correctly – that...
...Mr Cohen also testified that he bought and sold Wyeth shares on the recommendations of Mr Martoma and Wayne Holman, a close friend and former SAC portfolio manager who specialised in healthcare stocks, according...
...The next morning, Mr Martoma contacted Steve Cohen, founder of SAC, and they spoke for 20 minutes....
...The following morning, a Monday, SAC dumped its entire $700m position in Wyeth and Elan, co-developers of the drug, and bet that their share prices would fall....
...Six former SAC employees have pleaded guilty to insider trading while employed at the hedge fund founded by Steven Cohen in 1992. Mr Cohen has not been charged with criminal wrongdoing....
...Prosecutors allege Sidney Gilman, the chairman of the safety committee for the joint trial by drug companies Elan and Wyeth, was “flattered” by Mr Martoma and gave him the confidential results before they...
...on Elan and Wyeth was sound....
...Mr Cohen was not charged with any criminal activity....
...The hedge fund has agreed a $602m settlement of civil charges with the SEC relating to trading in two pharmaceutical stocks, Elan and Wyeth, without admitting or denying wrongdoing....
...It also says that a decision to sell short Elan – betting its price would fall – merely balanced a long position in Wyeth....
...Mr Martoma allegedly recommended to Steven Cohen, founder of the $15bn hedge fund, that SAC sell its positions in Wyeth and Elan, the developers of the Alzheimer drug, after gaining access to a confidential...
...Three days later Steven Cohen, founder of SAC, began dumping the fund’s entire position in Elan and Wyeth....
...They alleged that he sold shares in drug companies Wyeth and Elan based on non-public information that indicated results of a clinical trial would be disappointing....
...Authorities believe Dr Gilman told Mr Martoma the clinical drug trial results for a promising Alzheimer's drug developed by Elan and Wyeth were going to disappoint....
...Mr Cohen has not been accused of any wrongdoing....
...As previously reported, federal investigators examining SAC are looking into trading in stocks including Weight Watchers, InterMune, Elan, Wyeth and Dell....
...It was widely commented upon at the time that the authorities seemed to be getting ever closer to prosecuting SAC’s legendary boss, Steve Cohen....
...Mr Cohen began selling his stake in Elan and Wyeth, two pharmaceutical companies, after he had a 20-minute phone conversation with Mr Martoma, according to the indictment....
...US authorities say that SAC avoided losses of $194m and made $83m profit by betting against the share prices of pharmaceutical companies Wyeth and Elan ahead of the results of an Alzheimer’s drug trial....
...In court papers, prosecutors allege that the hedge fund founder sold all of his holdings of Elan and Wyeth stock, worth $700m, after a 20-minute phone call with Mr Martoma....
International Edition